Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

A

Assuta Hospital Systems

Status

Unknown

Conditions

Schizophrenia
Bipolar Disorder
Schizoaffective Disorder

Treatments

Behavioral: treatment as usual
Behavioral: intervention for improvement of adherence

Study type

Interventional

Funder types

Other

Identifiers

NCT02665611
2124-15-SMC

Details and patient eligibility

About

Moma call center will provide unique service -Remote monitoring and support for mental health patients .The aim of this reserch is reducing hospitalization and improve adherence, by reaching out and there for monitoring very closely .

Full description

"Moma" call center is a result of collaboration between Maccabi Health Services and The Gertner Institute of Epidemiology and Health Policy Research. The call center provides remote continuous monitoring and support for patients with chronic illnesses, and has been found useful for improvement in treatment adherence and other clinical measures in patients with diabetes and CHF. The current project focuses on patients diagnosed with schizophrenia, schizoaffective disorder and bipolar disorder. Patients that suffer from these disorders are prone to low adherence and are at risk for discontinuation of treatment and frequent relapses. The advantages of the "Moma" call-center include high availability, reaching out, collaboration between treatment centers and agents, and continuous remote monitoring. We hypothesize that these factors will enable improvement of support provided to these patients, early detection of their needs, connection with community care agents, monitoring of treatment adherence, and remote interventions targeted towards prevention of relapse.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Men & women,

  1. age 18-60 ,
  2. "Maccabi Health service" patients with diagnosis of: schizophrenia, Schizo - effective or Bipolar Dis.
  3. Must have 30 days or more of hospitalization (during 3 years). Treated with psychiatric medication.
  4. Living independently or with a help of a caregiver.
  5. Is able to provide written informed consent.

Exclusion criteria

  1. Violent, or suicidal.
  2. Drug\ Alcohol, addiction,
  3. End stage Disease (Cancer, ESRF act.)
  4. Non - in depended and without Care giver/legal guardian

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

intervention group
Experimental group
Description:
intervention for improvement of treatment adherence "Intervention group"- This group will be followed by the "MOMA" call center (By the MOMA nures every couple weeks and by the study coordinatore and the treating Doctor at special "visits" as the study required.) The group will be monitored according to number of parameters, including treatment Adherence.
Treatment:
Behavioral: intervention for improvement of adherence
control group
Experimental group
Description:
treatment as usual Control group- Treatment will continue as usual by the Doctor.(This group will allso be followed by the Study Coordinator at the same "visits" as the "Intervention group".The group will be monitored according to number of parameters, including treatment Adherence.
Treatment:
Behavioral: treatment as usual

Trial contacts and locations

0

Loading...

Central trial contact

Meytal L Kahlon, MA; Yifat L Danon, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems